BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 29, 2015
View Archived Issues
Roche reflects on accomplishments of second quarter 2015
Read More
Promising advances on the way towards a universal flu vaccine
Read More
3SBio acquires small molecule manufacturer Zhejiang Wansheng Pharmaceutical
Read More
Grant supports development of Minomic's antibody technology
Read More
Horizon collaborates with Fox Chase to study Actimmune with PD-1/PD-L1 inhibitors for cancer
Read More
Fujifilm Kyowa Kirin Biologics establishes joint venture with AstraZeneca
Read More
Phase III extension studies show long-term benefit of NX-1207 in BPH
Read More
FDA approves second phase II protocol for MN-001 in NASH
Read More
Shire reviews milestones of second quarter 2015
Read More
Boehringer Ingelheim ends BACE inhibitor collaboration and license agreement with Vitae
Read More
Creatine kinase levels are associated to ALS prognosis
Read More
Biomarker may speed diagnosis of oral squamous cell carcinoma
Read More
Avraham Pharmaceuticals reports results from phase IIb trial of ladostigil in MCI
Read More
Regeneron and Sanofi form immuno-oncology collaboration
Read More
FDA grants breakthrough therapy designation to lenvatinib for renal cell carcinoma
Read More
Azedra receives breakthrough therapy designation for pheochromocytoma and paraganglioma
Read More
Preliminary phase II results presented for VAC-3S HIV vaccine
Read More
EMA accepts filing of MAA for reslizumab
Read More
FDA accepts for review CSL Behring's BLA for rVIII-SingleChain therapy
Read More
Mallinckrodt to divest its contrast media business to Guerbet
Read More
Rosetta Genomics' oncogene mutation assay OncoGxSelect approved for clinical use
Read More
Nanjing Sanhome patent reports anti-HCV agents
Read More
Aurigene Discovery discloses RORgamma receptor ligands
Read More
KTandG Life Sciences patents NQO1 modulators
Read More
FDA accepts for review NDA for grazoprevir/elbasvir for hepatitis C
Read More
Hikma to acquire Roxane Laboratories
Read More
Takeda reports identification of PI3K inhibitors
Read More
Sanofi's first LixiLan phase III study meets primary endpoint
Read More